Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 7 studies | 29% ± 17% |
Insufficient scRNA-seq data for expression of F2RL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 98% | 1145.87 | 323 / 328 | 94% | 84.90 | 167 / 178 |
kidney | 100% | 1541.33 | 89 / 89 | 91% | 64.73 | 824 / 901 |
thymus | 94% | 480.25 | 614 / 653 | 78% | 24.03 | 473 / 605 |
stomach | 75% | 1535.32 | 269 / 359 | 96% | 85.12 | 275 / 286 |
lung | 80% | 374.42 | 462 / 578 | 86% | 44.39 | 996 / 1155 |
prostate | 60% | 238.02 | 146 / 245 | 91% | 45.95 | 457 / 502 |
intestine | 49% | 2439.25 | 469 / 966 | 98% | 99.50 | 519 / 527 |
bladder | 52% | 537.14 | 11 / 21 | 84% | 49.17 | 422 / 504 |
esophagus | 39% | 372.96 | 557 / 1445 | 97% | 86.51 | 177 / 183 |
liver | 68% | 438.99 | 154 / 226 | 51% | 20.18 | 206 / 406 |
breast | 39% | 172.68 | 179 / 459 | 56% | 11.41 | 630 / 1118 |
ovary | 7% | 35.56 | 13 / 180 | 84% | 23.38 | 360 / 430 |
uterus | 6% | 28.03 | 10 / 170 | 77% | 41.24 | 355 / 459 |
skin | 75% | 3088.55 | 1348 / 1809 | 8% | 3.06 | 39 / 472 |
spleen | 71% | 263.76 | 170 / 241 | 0% | 0 | 0 / 0 |
heart | 53% | 298.80 | 454 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 20.08 | 23 / 45 |
peripheral blood | 46% | 405.65 | 426 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 40% | 140.38 | 530 / 1335 | 0% | 0 | 0 / 0 |
brain | 8% | 33.19 | 214 / 2642 | 27% | 6.23 | 190 / 705 |
adrenal gland | 25% | 78.51 | 64 / 258 | 4% | 0.78 | 9 / 230 |
adipose | 4% | 20.85 | 48 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.46 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0046328 | Biological process | regulation of JNK cascade |
GO_0006954 | Biological process | inflammatory response |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0050921 | Biological process | positive regulation of chemotaxis |
GO_0045087 | Biological process | innate immune response |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0003104 | Biological process | positive regulation of glomerular filtration |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0051607 | Biological process | defense response to virus |
GO_2000341 | Biological process | regulation of chemokine (C-X-C motif) ligand 2 production |
GO_0097029 | Biological process | mature conventional dendritic cell differentiation |
GO_0070493 | Biological process | thrombin-activated receptor signaling pathway |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0007596 | Biological process | blood coagulation |
GO_0043311 | Biological process | positive regulation of eosinophil degranulation |
GO_0046676 | Biological process | negative regulation of insulin secretion |
GO_0034137 | Biological process | positive regulation of toll-like receptor 2 signaling pathway |
GO_0030193 | Biological process | regulation of blood coagulation |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0045217 | Biological process | cell-cell junction maintenance |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0034145 | Biological process | positive regulation of toll-like receptor 4 signaling pathway |
GO_0070661 | Biological process | leukocyte proliferation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_1900135 | Biological process | positive regulation of renin secretion into blood stream |
GO_0050900 | Biological process | leukocyte migration |
GO_0034140 | Biological process | negative regulation of toll-like receptor 3 signaling pathway |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0070963 | Biological process | positive regulation of neutrophil mediated killing of gram-negative bacterium |
GO_0032682 | Biological process | negative regulation of chemokine production |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0032930 | Biological process | positive regulation of superoxide anion generation |
GO_0061028 | Biological process | establishment of endothelial barrier |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0030836 | Biological process | positive regulation of actin filament depolymerization |
GO_0099109 | Biological process | potassium channel activating, G protein-coupled receptor signaling pathway |
GO_0031274 | Biological process | positive regulation of pseudopodium assembly |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0050927 | Biological process | positive regulation of positive chemotaxis |
GO_0042311 | Biological process | vasodilation |
GO_0060100 | Biological process | positive regulation of phagocytosis, engulfment |
GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0034141 | Biological process | positive regulation of toll-like receptor 3 signaling pathway |
GO_0002690 | Biological process | positive regulation of leukocyte chemotaxis |
GO_0042119 | Biological process | neutrophil activation |
GO_0002286 | Biological process | T cell activation involved in immune response |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031143 | Cellular component | pseudopodium |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0031681 | Molecular function | G-protein beta-subunit binding |
GO_0001965 | Molecular function | G-protein alpha-subunit binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0002020 | Molecular function | protease binding |
GO_0015057 | Molecular function | thrombin-activated receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | F2RL1 |
Protein name | Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2R like trypsin receptor 1 |
Synonyms | GPR11 PAR2 |
Description | FUNCTION: Receptor for trypsin and trypsin-like enzymes coupled to G proteins . Its function is mediated through the activation of several signaling pathways including phospholipase C (PLC), intracellular calcium, mitogen-activated protein kinase (MAPK), I-kappaB kinase/NF-kappaB and Rho . Can also be transactivated by cleaved F2R/PAR1. Involved in modulation of inflammatory responses and regulation of innate and adaptive immunity, and acts as a sensor for proteolytic enzymes generated during infection. Generally is promoting inflammation. Can signal synergistically with TLR4 and probably TLR2 in inflammatory responses and modulates TLR3 signaling. Has a protective role in establishing the endothelial barrier; the activity involves coagulation factor X. Regulates endothelial cell barrier integrity during neutrophil extravasation, probably following proteolytic cleavage by PRTN3 . Proposed to have a bronchoprotective role in airway epithelium, but also shown to compromise the airway epithelial barrier by interrupting E-cadherin adhesion . Involved in the regulation of vascular tone; activation results in hypotension presumably mediated by vasodilation. Associates with a subset of G proteins alpha subunits such as GNAQ, GNA11, GNA14, GNA12 and GNA13, but probably not with G(o)-alpha, G(i) subunit alpha-1 and G(i) subunit alpha-2. However, according to PubMed:21627585 can signal through G(i) subunit alpha. Believed to be a class B receptor which internalizes as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptor, for extended periods of time. Mediates inhibition of TNF-alpha stimulated JNK phosphorylation via coupling to GNAQ and GNA11; the function involves dissociation of RIPK1 and TRADD from TNFR1. Mediates phosphorylation of nuclear factor NF-kappa-B RELA subunit at 'Ser-536'; the function involves IKBKB and is predominantly independent of G proteins. Involved in cellular migration. Involved in cytoskeletal rearrangement and chemotaxis through beta-arrestin-promoted scaffolds; the function is independent of GNAQ and GNA11 and involves promotion of cofilin dephosphorylation and actin filament severing. Induces redistribution of COPS5 from the plasma membrane to the cytosol and activation of the JNK cascade is mediated by COPS5. Involved in the recruitment of leukocytes to the sites of inflammation and is the major PAR receptor capable of modulating eosinophil function such as pro-inflammatory cytokine secretion, superoxide production and degranulation. During inflammation promotes dendritic cell maturation, trafficking to the lymph nodes and subsequent T-cell activation. Involved in antimicrobial response of innate immune cells; activation enhances phagocytosis of Gram-positive and killing of Gram-negative bacteria. Acts synergistically with interferon-gamma in enhancing antiviral responses. Implicated in a number of acute and chronic inflammatory diseases such as of the joints, lungs, brain, gastrointestinal tract, periodontium, skin, and vascular systems, and in autoimmune disorders. . |
Accessions | P55085 ENST00000514165.1 ENST00000296677.5 D6RJH3 |